I think considering approx 2.80 was the March 2020 Covid panic low, and that after getting a monster fine it didnt really break 2.80, it's safe to say that 2.80 is a long term double bottom (year on year) and one would be wise to invest in in this for the long haul for a expansionist recovery.

eh 25cents after this record quarter, and similar payout ratio will see approx 30c next quarter, assuming they continue paying out special dividends

That's 10% dividend yield in 6 months?

No brainer.

Basic Facts. Public Service Announcement.


1) Year on year the company has gone from 8c low to 32c (split adjusted)

2) Since the disposal of shares from the former owner (July 1), the shares have gone from 24c to 32c (split adjusted), high of 90c.

3) The private placement to replace and rejuvenate the company with fresh funds was handled by a local investment bank via bookbuild to raise approximately 60m from the market for revival and expansion purposes.

4) The losses have narrowed in the past quarter on quarter (under new management and new business model) DURING Covid pandemic.

5) Their masks ARE listed on the FDA website. Obtained from the Bursa announcement yesterday.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=726352&lpcd=QKR